-
Among adults diagnosed with heart failure who had no prior statin use, incident statin use was independently associated with lower risks of death and hospitalization among patients with or without coronary heart disease.
-
Treatment with atorvastatin 40 mg/d, initiated 7 days before surgery, significantly reduces the incidence of postoperative AF after elective cardiac surgery with cardiopulmonary bypass and shortens hospital stay.
-
RFA should be considered a first-line therapy even after the first episode of symptomatic AFL.
-
Physical counterpressure maneuvers are a risk-free, effective, and low-cost treatment method in patients with vasovagal syncope and recognizable prodromal symptoms.
-
Hypertension, ischemic heart disease, left ventricular hypertrophy, ST-T abnormalities, and an increased cardiothoracic ratio were associated with LBBB.
-
In response to several high-profile drug misadventures including the rofecoxib (Vioxx®) withdrawal from the market, the FDA's Center for Drug Evaluation and Research (CDER) asked the Institute of Medicine (IOM) to assess the drug safety system in the United States.
-
-
Observations with new drug-eluting stents have suggested that percutaneous coronary intervention (PCI) on left main coronary artery stenosis unprotected by a bypass graft may be safe and effective.
-
The new 64-slice cardiovascular computed tomography (CVCT) is theoretically superior to the old 16-slice CT for detecting coronary artery disease (CAD).
-
Several observational studies, as well as some animal research have suggested a beneficial role of statins in subjects with acute bacterial infection and sepsis. The hypothesis that statins may manifest non-lipid actions (pleiotropic effects) has been a popular theme for years.
